SYROS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.04 USD | -1.18% |
|
+11.01% | -35.30% |
| Apr. 09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| Apr. 09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
Chart calendar Syros Pharmaceuticals, Inc.
e1f45966fd483c2a68.8f8EuT4-LMb8Gojau2CrMvi16LcsDL0A6NLJrEAyfto.k4tgwA5Yeb6kb--i8SL8VZvlpvFhY89qgLm6w21EO523jlGLW3plgKQizQ~17696dd3b24733ff12e0c379dc539806
Upcoming events on Syros Pharmaceuticals, Inc.
Past events on Syros Pharmaceuticals, Inc.
| 2024-03-27 08:30 am | Q4 2023 Earnings Call |
| 2024-03-27 07:30 am | Q4 2023 Earnings Release |
| 2024-03-05 09:10 am | TD Cowen Health Care Conference |
| 2023-12-06 11:00 am | The JMP Securities Hemaology and Oncology Summit |
| 2023-12-06 08:30 am | SELECT-AML-1 Phase 2 Trial Results Call |
| 2023-11-28 02:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-14 08:30 am | Q3 2023 Earnings Call |
| 2023-11-14 07:30 am | Q3 2023 Earnings Release |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 07:30 am | Q2 2023 Earnings Release |
| 2023-06-15 10:00 am | Sidoti Small-Cap Virtual Conference |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract No 3080 |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract No 3081 |
| 2023-06-01 09:00 am | Annual General Meeting |
| 2023-05-16 10:00 am | JMP Securities Life Sciences Conference |
| 2023-05-10 08:30 am | Q1 2023 Earnings Call |
| 2023-05-10 07:30 am | Q1 2023 Earnings Release |
| 2023-03-13 08:00 am | Oppenheimer Healthcare Conference |
| 2023-03-07 09:10 am | Cowen Health Care Conference |
| 2023-03-02 08:30 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,98 2,16 -8.13% | 15,1 12,1 24.83% | 23,5 20,4 14.96% | 14,9 19,5 -23.56% | 9,94 11,5 -13.75% | 2,80 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -77,7 -79,0 1.57% | -82,3 -78,2 -5.28% | -99,4 -103 3.05% | -136 -125 -8.72% | -129 -138 6.54% | -119 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -75,4 -76,8 1.83% | -84,0 -79,3 -6.04% | -86,6 -94,1 8.03% | -94,7 -116 18.65% | -165 -136 -21.16% | -128 |
|
Net income Million USD | Released Forecast Spread | -75,4 -76,7 1.64% | -84,0 -78,9 -6.47% | -86,6 -94,5 8.38% | -94,7 -117 19.12% | -165 -135 -22.21% | -125 |
|
EPS USD | Released Forecast Spread | -18,8 -18,8 0.23% | -18,2 -17,0 -6.88% | -13,8 -15,1 8.52% | -7,49 -9,66 22.45% | -5,81 -4,73 -22.73% | -3,69 |
| Announcement Date | 05/03/20 | 04/03/21 | 15/03/22 | 02/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,80 4,84 61.17% | 5,47 4,92 11.12% | 6,28 4,78 31.21% | 3,89 4,85 -19.77% | -0,75 3,85 -119.58% | 2,95 3,30 -10.48% | 2,83 3,50 -19.06% | 3,76 3,94 -4.52% | 0,39 2,00 -80.7% | 0,72 | 0,72 | 0,72 | 0,72 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -25,4 -28,6 10.97% | -26,7 -29,4 9.19% | -33,8 -26,4 -27.87% | -39,5 -30,7 -28.52% | -36,0 -30,8 -16.86% | -33,2 -31,7 -4.77% | -34,0 -34,3 1% | -34,6 -35,0 1.16% | -27,1 -36,8 26.27% | -27,8 | -29,1 | -29,3 | -32,9 | -36,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,8 -28,7 17.11% | -25,1 -29,6 15.05% | -34,5 -25,9 -33.13% | -30,3 -31,4 3.77% | -4,77 -30,3 84.23% | -23,8 -29,6 19.58% | -36,3 -31,5 -15.18% | -40,1 -31,9 -25.94% | -64,4 -35,6 -80.68% | -29,8 | -31,3 | -31,7 | -35,3 | -36,5 |
|
Net income Million USD | Released Forecast Spread | -23,8 -28,7 17.11% | -25,1 -29,6 15.05% | -34,5 -25,9 -33.13% | -30,3 -31,4 3.77% | -4,77 -30,3 84.23% | -23,8 -29,6 19.58% | -36,3 -31,5 -15.18% | -40,1 -31,9 -25.94% | -64,4 -35,6 -80.68% | -29,8 | -31,3 | -31,7 | -35,3 | -36,5 |
|
EPS USD | Released Forecast Spread | -3,80 -4,59 17.17% | -4,00 -4,70 14.89% | -5,40 -4,08 -32.35% | -3,21 -3,99 19.48% | -0,17 -1,30 86.91% | -0,85 -1,05 18.92% | -1,30 -1,13 -15.25% | -1,43 -1,14 -25.44% | -2,22 -1,14 -94.06% | -0,87 | -0,91 | -0,91 | -1,00 | -0,92 |
| Announcement Date | 15/03/22 | 16/05/22 | 09/08/22 | 14/11/22 | 02/03/23 | 10/05/23 | 08/08/23 | 14/11/23 | 27/03/24 | - | - | - | - | - |
More events
Past sector events for Syros Pharmaceuticals, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYRS Stock
- Calendar Syros Pharmaceuticals, Inc.
